MEDICINOVA INC (MNOV) Form 8-K — Aug 19, 2026
On August 17, 2026, MediciNova entered into new executive employment agreements with President and CEO Yuichi Iwaki and Chief Medical Officer Kazuko Matsuda, superseding their prior employment and severance protection arrangements. Both executives continue in their current roles. Under the new terms, Dr. Iwaki receives an annual base salary of $690,246 with a target annual bonus of 55% of base salary, while Dr.
Key figures
- Employment nature
- at-will, Delaware law
- Iwaki base salary
- 690246
- Non cic severance
- 12 months base salary plus 12 months COBRA
- Iwaki target bonus
- 55% of base salary
- Iwaki cic severance
- 24 months base salary plus 24 months target bonus, 18 months COBRA, 100% equity acceleration
- Matsuda base salary
- 540143
- Matsuda target bonus
- 40% of base salary
- Matsuda cic severance
- 18 months base salary plus 18 months target bonus, 18 months COBRA, 100% equity acceleration
- Non solicitation period
- 1 year post-termination
Price after filing
1 day: -0.7%7 days: +7.2%30 days: +150.0%
Close on the filing date to close N calendar days later (from $1.38). Historical, not a forecast.
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.